LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE UVIDEA XL DAILY PROTECTION MELT IN CREAM SPF50

Active ingredient:

octyl methoxycinnamate, Quantity: 70.929 mg/g; titanium dioxide, Quantity: 33.2 mg/g; bemotrizinol, Quantity: 15 mg/g; diethylamino hydroxybenzoyl hexyl benzoate, Quantity: 20 mg/g; ecamsule, Quantity: 24.75 mg/g; drometrizole trisiloxane, Quantity: 60 mg/g

Available from:

L'Oreal Australia Pty Ltd

INN (International Name):

Bemotrizinol,diethylamino hydroxybenzoyl hexyl benzoate,Drometrizole trisiloxane,Ecamsule,octyl methoxycinnamate,titanium dioxid

Pharmaceutical form:

Cream

Composition:

Excipient Ingredients: dimeticone 350; aluminium hydroxide hydrate; trolamine; Vitellaria paradoxa; stearic acid; propylene glycol; caprylyl glycol; disodium edetate; PEG-100 stearate; carbomer 980; ethanol; cetyl alcohol; phenoxyethanol; xanthan gum; trometamol; glyceryl monostearate; palmitic acid; purified water; dl-alpha-tocopherol; glycerol; potassium cetyl phosphate; 1,3-butylene glycol; pentylene glycol; sodium cocoyl sarcosinate

Administration route:

Topical

Therapeutic indications:

May assist in preventing some skin cancers (sunscreen) ; May reduce the risk of some skin cancers (sunscreen) ; SPF 50 Broad spectrum high protection sunscreen ; Can aid in the prevention of premature skin ageing (sunscreen) ; Can aid in the prevention of solar keratosis (sunscreen) ; Can aid in the prevention of sunspots (sunscreen)

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2014-03-24